Jiří Klečka

Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder

Christopher R. Chapple, Steven A. Kaplan, David Mitcheson et al. · European Urology · 2012 · 350 citations

Urological Research, Urology, Voiding Dysfunction +6

Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

Renato D. Lópes, Celestia S. Higano, Susan F. Slovin et al. · Circulation · 2021 · 141 citations · Full text

Tumours in End-Stage Kidney

Milan Hora, Ondřej Hes, Tomáš Reischig et al. · Transplantation Proceedings · 2008 · 58 citations

Urology, Tumoral Pathology, Kidney Transplant +11

Importance of miR-20a expression in prostate cancer tissue.

Martin Pešta, Jiří Klečka, Vlastimil Kulda et al. · PubMed · 2010 · 46 citations

Extensively Cystic Renal Neoplasms in Adults (Bosniak Classification II or III) – Possible “Common” Histological Diagnoses: Multilocular Cystic Renal Cell Carcinoma, Cystic Nephroma, and Mixed Epithelial and Stromal Tumor of the Kidney

Milan Hora, Ondřej Hes, Michal Michal et al. · International Urology and Nephrology · 2005 · 39 citations

Urology, Cystic Renal Neoplasms, Cystic Nephroma +8